BioCentury

12:02 AM GMT, Jul 30, 2009
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Financial News

ViroPharma reports earnings, Cinryze guidance

ViroPharma Inc. (NASDAQ:VPHM) reported diluted GAAP EPS of $0.20, beating by $0.02 the Street's estimate of $0.18, but down 31%

Read the full 203 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.